Apellis Pharmaceuticals, Inc. · NASDAQ:APLS

BlackRock, Inc. reported a 10.50% stake in Apellis Pharmaceuticals, Inc. (Schedule 13G)

Event Jan 31, 2026 · Filed Feb 6, 2026

BlackRock, Inc. reported a 10.50% stake in Apellis Pharmaceuticals, Inc., 13,228,073 shares, as a passive investor on Jan 31, 2026. Filed Feb 6, 2026 (Schedule 13G).

Stake
10.50%
Shares
13,228,073
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.10.50%13,228,073

Source

View original at SEC

Related